What is a stock summary page? Click here for an overview.
Business Description

ConvaTec Group PLC
ISIN : GB00BD3VFW73
Description
Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.71 | |||||
Debt-to-EBITDA | 2.23 | |||||
Interest Coverage | 4.51 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.91 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.2 | |||||
3-Year EBITDA Growth Rate | 12 | |||||
3-Year EPS without NRI Growth Rate | 7 | |||||
3-Year FCF Growth Rate | 9.9 | |||||
3-Year Book Growth Rate | 1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 11.77 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.41 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 0.42 | |||||
9-Day RSI | 7.53 | |||||
14-Day RSI | 23 | |||||
3-1 Month Momentum % | 6.57 | |||||
6-1 Month Momentum % | 13.65 | |||||
12-1 Month Momentum % | -18.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.55 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 136.09 | |||||
Days Sales Outstanding | 46.81 | |||||
Days Payable | 70.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.11 | |||||
Dividend Payout Ratio | 0.41 | |||||
3-Year Dividend Growth Rate | 6 | |||||
Forward Dividend Yield % | 2.15 | |||||
5-Year Yield-on-Cost % | 2.57 | |||||
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 3.37 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.07 | |||||
Operating Margin % | 14.49 | |||||
Net Margin % | 8.33 | |||||
FCF Margin % | 11.97 | |||||
ROE % | 11.35 | |||||
ROA % | 5.27 | |||||
ROIC % | 7.79 | |||||
3-Year ROIIC % | 27.03 | |||||
ROC (Joel Greenblatt) % | 38.46 | |||||
ROCE % | 10.17 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 34.92 | |||||
Forward PE Ratio | 19.11 | |||||
PE Ratio without NRI | 21.71 | |||||
Shiller PE Ratio | 104.77 | |||||
Price-to-Owner-Earnings | 17.82 | |||||
PEG Ratio | 2.15 | |||||
PS Ratio | 2.94 | |||||
PB Ratio | 3.96 | |||||
Price-to-Free-Cash-Flow | 24.38 | |||||
Price-to-Operating-Cash-Flow | 17 | |||||
EV-to-EBIT | 24.45 | |||||
EV-to-Forward-EBIT | 21.43 | |||||
EV-to-EBITDA | 14.46 | |||||
EV-to-Forward-EBITDA | 12.91 | |||||
EV-to-Revenue | 3.41 | |||||
EV-to-Forward-Revenue | 3.26 | |||||
EV-to-FCF | 28.43 | |||||
Price-to-GF-Value | 0.92 | |||||
Price-to-Projected-FCF | 1.75 | |||||
Price-to-DCF (Earnings Based) | 1.6 | |||||
Price-to-DCF (FCF Based) | 0.76 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.14 | |||||
Earnings Yield (Greenblatt) % | 4.09 | |||||
FCF Yield % | 4.1 | |||||
Forward Rate of Return (Yacktman) % | 13.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CNVVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ConvaTec Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2,289.2 | ||
EPS (TTM) ($) | 0.093 | ||
Beta | 0.39 | ||
3-Year Sharpe Ratio | 0.34 | ||
3-Year Sortino Ratio | 0.61 | ||
Volatility % | 25.47 | ||
14-Day RSI | 23 | ||
14-Day ATR ($) | 0.004691 | ||
20-Day SMA ($) | 3.048 | ||
12-1 Month Momentum % | -18.95 | ||
52-Week Range ($) | 2.71 - 3.88 | ||
Shares Outstanding (Mil) | 2,044.34 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ConvaTec Group PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ConvaTec Group PLC Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
ConvaTec Group PLC Frequently Asked Questions
What is ConvaTec Group PLC(CNVVF)'s stock price today?
The current price of CNVVF is $3.00. The 52 week high of CNVVF is $3.88 and 52 week low is $2.71.
When is next earnings date of ConvaTec Group PLC(CNVVF)?
The next earnings date of ConvaTec Group PLC(CNVVF) is 2025-07-30 Est..
Does ConvaTec Group PLC(CNVVF) pay dividends? If so, how much?
The Dividend Yield %  of ConvaTec Group PLC(CNVVF) is 2.11% (As of Today), Highest Dividend Payout Ratio of ConvaTec Group PLC(CNVVF) was 0.49. The lowest was 0.08. And the median was 0.45. The  Forward Dividend Yield % of ConvaTec Group PLC(CNVVF) is 2.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |